Aptorum Group Limited: Aptorum Group Regains Compliance with

Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) ("Aptorum Group" or "Aptorum"), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology

Related Keywords

Singapore , Craig Brelsford , Ghislaine Gasparetto , Aptorum Group Form , Aptorum Group Or , Hearing Panel , Investor Relations Department , Singapore Agency For Science , Actifin Financial Communications Europe , Redchip Financial Communications United States , Nasdaq , Company Classa Ordinary , Daptorum Group , Aptorum Group Limited Nasdaq , Nasdaq Stock Market , Nasdaq Listing Qualifications Department , Regulatory News , Group Limited , Euronext Paris , Listing Qualifications Department , Nasdaq Listing Rule , Ordinary Shares , Nasdaq Global Market , Nasdaq Capital , Aptorum Group Limited , Private Securities Litigation Reform Act , French Autorit , Des March , Regulations Delegated , Relations Department , Financial Communications United States , Financial Communications Europe , Marcel Torney , Aptorum , Group , Imited , Regains , Compliance , Minimum , Price , Eceives , Notification , Market , Value , Publicly , Held , Hares , Deficiency ,